Shandong Jincheng Pharmaceutical Group Co., Ltd. (300233)

Overview

Shandong Jincheng Pharmaceutical Group Co., Ltd is a prominent player in the pharmaceutical industry, engaged in a wide range of activities encompassing the research and development, production, marketing, and sales of Cephalosporin intermediates, not just within China but on an international scale as well. Established in 2004 and headquartered in Zibo, China, the company has expanded its portfolio to include a diverse array of pharmaceutical and medico-chemical products and services. With a comprehensive product lineup and extensive services, Shandong Jincheng Pharmaceutical Group stands as a key contributor to the global pharmaceutical and biopharmaceutical sectors, leveraging its capabilities in Active Pharmaceutical Ingredients (APIs) and more to meet the varied needs of its clientele worldwide.

Products and Services

• Active Pharmaceutical Ingredients (APIs): The backbone of many drugs, these substances are the crucial components that produce the intended effects of medications. Shandong Jincheng Pharmaceutical Group specializes in the production of APIs, contributing critical components for various drug formulations.
• Biopharmaceuticals: This segment includes a range of products developed using biological processes. Unlike traditional synthetic pharmaceuticals, biopharmaceuticals involve complex molecules or mixtures of molecules made from living organisms. The company's entry into this area signifies its commitment to innovative healthcare solutions.
• Medical Intermediates: These are the precursor chemicals in the synthesis of pharmaceutical drugs. Shandong Jincheng Pharmaceutical Group produces intermediates essential for the creation of complex drugs, highlighting its role in simplifying the production process for pharmaceutical companies.
• Fine Chemicals: Specialized chemicals produced in limited quantities for specific applications, fine chemicals are used in the pharmaceutical industry for research and drug development. The company's capability to produce these chemicals underlines its versatility and technical proficiency.
• Finished Dosages: This aspect of the company's portfolio encompasses the final form of pharmaceutical drugs, ready for consumption by patients. Shandong Jincheng's involvement in this segment ensures quality control from raw materials to finished products, guaranteeing patient safety and efficacy.
• Pharmaceutical Products: A broad category that includes various formulations and types of medicines manufactured by the company. These range from generic to proprietary drugs, serving a wide spectrum of therapeutic areas.
• Animal Nutrition and Health Care: Diversifying beyond human pharmaceuticals, the company also provides products aimed at improving the health and nutritional status of animals. This reflects a comprehensive approach to healthcare, extending its expertise to veterinary products.
• CMO and CDMO Services: Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) services underscore the company's capacity to partner with other pharmaceutical firms. It offers end-to-end services, including drug development, manufacturing, and even packaging, providing a full spectrum of support to its clients in the pharmaceutical industry.